Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician (Q41465989)

1 October 2017

1 reference

title

Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician (English)

1 reference

bronchopulmonary dysplasia

1 October 2017

main subject

1 reference

Farrell PA

1 reference

1 October 2017

Fiascone JM

series ordinal

1 reference

1 October 2017

publication date

1 April 1997

1 reference

Current problems in pediatrics

1 October 2017

published in

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

129-163

1 reference

Bronchopulmonary dysplasia: Clinical presentation

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. The HIFI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants: assessment of pulmonary function at 9 months of corrected age. HiFi Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Newborn tracheal aspirate cytology: Classification during respiratory distress syndrome and bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Plasma xanthine oxidase activity and lipid hydroperoxide levels in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Morphometric analysis of the lung in bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Tracheobronchial abnormalities in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Large airway collapse in bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Improvement in lung mechanics as a function of age in the infant with severe bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Improving pulmonary function does not decrease oxygen consumption in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Serial determination of pulmonary function in infants with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Pulmonary function until two years of life in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Longitudinal changes in lung function during the first three years of premature infants with moderate to severe bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Late pulmonary sequelae of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Expiratory flow limitation in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Bronchopulmonary dysplasia: improvement in lung function between 7 and 10 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Controlled trial of furosemide therapy in infants with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Drug therapy for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Pulmonary hypertension in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Long-term follow-up of bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Respiratory syncytial virus-related apnea in infants. Demographics and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Health of very low birth weight children during their first eight years

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Growth status and growth rates of a varied sample of low birth weight, preterm infants: a longitudinal cohort from birth to three years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Growth failure in bronchopulmonary dysplasia: elevated metabolic rates and pulmonary mechanics.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Growth of low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Risk factors for major neurodevelopmental impairments and need for special education resources in extremely premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Effect of medical and social risk factors on outcome of prematurity and very low birth weight

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Early educational intervention for very low birth weight infants: Results from the infant health and development program

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Severe bronchopulmonary dysplasia. Predictors of survival and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Outpatient Management and Follow-Up of Bronchopulmonary Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Ventilatory changes in convalescent infants positioned in car seats

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

School-age outcomes in children with birth weights under 750 g.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Prematurity is associated with abnormal airway function in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-9380%2897%2980017-5

7 January 2021

10.1016/S0045-9380(97)80017-5

Identifiers

DOI

1 reference

1 October 2017

1 reference